Grace Therapeutics, Inc. - Form 4 Filing

Opaleye Management Inc., a 10% owner, reported the acquisition of Grace Therapeutics, Inc. Common Stock. On September 8, 2026, 9,393 shares were acquired at a weighted average price of $2.0972 per share. Subsequently, on September 9, 2026, an additional 5,836 shares were acquired at a weighted average price of $2.0899 per share. These transactions were made through Opaleye, L.P. The total post-transaction shares owned by Opaleye Management Inc. are 2,775,229. The reporting person disclaims beneficial ownership except to the extent of their pecuniary interest.